PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Hexabromocyclododecane (HBCDD)
and all major diastereoisomers identified
show/hide
|
- | - | - | - | - | - | - | 1 | 1 | 1 | - | Details |
| halosulfuron-methyl (ISO); methyl 3-chloro-5-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-1-methyl-1H-pyrazole-4-carboxylate | 600-130-3 | 100784-20-1 | - | - | - | - | - | 1 | - | - | - | Details |
| Glyoxylic acid | 206-058-5 | 298-12-4 | - | - | 2 | - | - | 1 | - | - | - | Details |
| glyoxal … %; ethandial … % | 203-474-9 | 107-22-2 | - | - | 2 | - | - | 1 | - | - | - | Details |
| Glutaral | 203-856-5 | 111-30-8 | - | - | - | - | 1 | 1 | 1 | 1 | - | Details |
| Geraniol | 203-377-1 | 106-24-1 | - | - | 4 | 1 | - | 1 | - | - | - | Details |
|
Garlic, ext.
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Allium sativum, Liliaceae.
|
232-371-1 | 8008-99-9 | - | - | - | - | - | 1 | - | - | - | Details |
| Gallium arsenide | 215-114-8 | 1303-00-0 | - | - | 1 | - | - | 1 | - | - | - | Details |
| Fuberidazole | 223-404-0 | 3878-19-1 | - | - | - | - | - | 1 | - | - | - | Details |
| Formic acid | 200-579-1 | 64-18-6 | - | - | 1 | 1 | 1 | 1 | - | - | - | Details |